Title:
REMEDIES FOR BRAIN INFARCTION
Document Type and Number:
WIPO Patent Application WO/1999/044639
Kind Code:
A1
Abstract:
Remedies for brain infarction which contain as the active ingredient a compound having mGluR1 antagonism; medicinal compositions which are remedies for brain infarction at the acute stage; medicinal compositions which contain as the active ingredient a compound having selective mGluR1 antagonism; and medicinal compositions wherein the compound having selective mGluR1 antagonism is 6-amino-N-cyclohexyl-N,3-dimethylthiazolo[3,2-a]benzimidazole-2-carboxamide dihydrochloride. Means for Solution: Since a compound having mGluR1 antagonism shows an effect of reducing infarction volume in a rat brain infarction model, it is found out that mGluR1 antagonists are useful in preventing and treating brain infarction.
More Like This:
WO/2023/288100 | LIPOSOMAL FORMULATIONS OF BCL INHIBITORS |
WO/2018/023060 | SMALL MOLECULE INHIBITORS FOR TRANSCRIPTION FACTORS |
WO/2014/111580 | UROLITHIN B FOR MUSCLE GROWTH |
Inventors:
OKADA MASAMICHI (JP)
TAKAHASHI MASAYASU (JP)
HAYASHIBE SATOSHI (JP)
TAKAHASHI MASAYASU (JP)
HAYASHIBE SATOSHI (JP)
Application Number:
PCT/JP1999/000995
Publication Date:
September 10, 1999
Filing Date:
March 02, 1999
Export Citation:
Assignee:
YAMANOUCHI PHARMA CO LTD (JP)
OKADA MASAMICHI (JP)
TAKAHASHI MASAYASU (JP)
HAYASHIBE SATOSHI (JP)
OKADA MASAMICHI (JP)
TAKAHASHI MASAYASU (JP)
HAYASHIBE SATOSHI (JP)
International Classes:
A61K31/00; A61K31/428; A61K31/429; (IPC1-7): A61K45/00; A61K31/425
Foreign References:
JPH08169884A | 1996-07-02 |
Other References:
See also references of EP 1059090A4
Attorney, Agent or Firm:
Nagai, Shozo (Ltd. Patent Dept. 17-1, Hasune 3-chome Itabashi-ku Tokyo, JP)
Download PDF:
Previous Patent: IL-12 ENHANCEMENT OF IMMUNE RESPONSES TO T-INDEPENDENT ANTIGENS
Next Patent: TRANSMUCOUS SORBEFACIENTS
Next Patent: TRANSMUCOUS SORBEFACIENTS